Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 14/20 | 0.91 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | SHBG | P04278 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.57 |
| ▸ | PGR | P06401 | 2/20 | 0.57 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.57 |
| ▸ | AR | P10275 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | SNCA | P37840 | 2/20 | 0.57 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.57 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.57 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.57 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12430769 | 0.95 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL4361013 | 0.95 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL13787743 | 0.95 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL4431797 | 0.95 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL13752636 | 0.95 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL15903 | 0.95 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL13001778 | 0.95 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| SCHEMBL11020843 | 0.95 | CYP19A1 (1.00) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| Diethylamine SCHEMBL8741602 | 0.88 | CYP19A1 (0.85) | CYP19A1LMNAMAPTSHBGCYP3A4 | |
| Propionic Acid SCHEMBL29224763 | 0.88 | CYP19A1 (0.85) | CYP19A1LMNAMAPTSHBGCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230149519-A1 | VARIANT SULFATASE ENZYMES WITH ENHANCED PROPERTIES | INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. | 2023-05-18 | — | — | US | claimed |
| US-12076377-B2 | Variant sulfatase enzymes with enhanced properties | INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. (US) | 2024-09-03 | — | — | US | disclosed |
| US-20230149519-A1 | VARIANT SULFATASE ENZYMES WITH ENHANCED PROPERTIES | INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. | 2023-05-18 | — | — | US | disclosed |
| US-9724262-B2 | Methods of diagnosing and treating neonatal reversion to fetal consciousness | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-08-08 | — | — | US | disclosed |
| US-20160242994-A1 | METHODS OF DIAGNOSING AND TREATING NEONATAL REVERSION TO FETAL CONSCIOUSNESS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-08-25 | — | — | US | disclosed |
| US-9339433-B2 | Methods of diagnosing and treating neonatal reversion to fetal consciousness | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-05-17 | — | — | US | disclosed |
| US-20140213563-A1 | METHODS OF DIAGNOSING AND TREATING NEONATAL REVERSION TO FETAL CONSCIOUSNESS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-07-31 | — | — | US | disclosed |